首页/数据集/Supplementary Data for "Quantifying the Risk of Drug-Associated Skin Hyperpigmentation Relative to the General Population: A National Cohort Study Using TriNetX"

Supplementary Data for "Quantifying the Risk of Drug-Associated Skin Hyperpigmentation Relative to the General Population: A National Cohort Study Using TriNetX"

Mendeley Data2026-04-18 收录

药物不良反应监测

皮肤色素沉着风险

数据链接：

https://data.mendeley.com/datasets/scsbz22jmt 数据链接链接失效反馈

官方服务：

资源简介：

Supplementary data for manuscript

应用场景：

创建时间：

2025-08-18

药物不良反应监测

医学影像安全

Patients with a reported adverse reaction to a Gadolinium-based contrast agent.

Figshare2020-04-03 更新70

Safety outcomes in the patients who received an injection of the investigational product.

临床试验安全性评估

药物不良反应监测

Safety outcomes in the patients who received an injection of the investigational product.

Figshare2019-12-10 更新50

Overall summary of adverse events (treated set).

药物不良反应监测

临床试验安全性分析

aPatients were randomised 2:2:1 to the tiotropium Respimat 5 μg, tiotropium Respimat 2.5 μg and placebo Respimat groups, respectively. bAs determined by the investigator. cElevation of aspartate amino

NIAID Data Ecosystem20

邯郸市馆陶县-卫生-医院用药方法数据

临床用药管理

药物不良反应监测

馆陶县人民医院在开展医疗服务过程中产生的医院用药方法数据，包含药品名称、剂型剂量、给药途径、频次疗程、用药反应等。可用于合理用药指导、药效研究、不良反应监测。

河北省公共数据资源登记平台70

Rapid Ventricular Tachycardias Associated with Cilostazol Use

药物不良反应监测

心血管事件风险

A 92-year-old woman with normal systolic function had recently begun using the newly approved phosphodiesterase III inhibitor cilostazol when she was admitted with lower-extremity pain. Cilostazol is

PubMed Central30

Supplementary Data for "Quantifying the Risk of Drug-Associated Skin Hyperpigmentation Relative to the General Population: A National Cohort Study Using TriNetX"

资源简介：

相关数据集